Analyst firms · Oppenheimer · CARR
Oppenheimer CARR price target and rating history
Carrier Global Corporation (CARR) · Industrials
Oppenheimer rates Carrier Global Corporation (CARR) Perform with a $74 price target, as of its latest action on Oct 14, 2025. It has published 3 rating actions on CARR since March 2023, including 0 upgrades and 1 downgrade. Across 5 firms with a CARR price target in the last 12 months, the median target is $67.
- Current rating
- Perform
- Price target
- $74
- Median target, all firms
- $67
- Actions on CARR
- 3
Oppenheimer price target on CARR
Every Oppenheimer rating on CARR
- Oct 14, 2025
- Aug 16, 2024
- Mar 28, 2023
How other firms rate CARR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Goldman Sachs | Neutral | $61 | Oct 14, 2026 |
| Wells Fargo | Overweight | $67 | Sep 25, 2026 |
| Bernstein | Mkt Perform | $75 | Jun 10, 2026 |
| BNP Paribas Exane | Neutral | $62 | Apr 14, 2026 |
| Evercore ISI | Outperform | $75 | Apr 13, 2026 |
Questions about Oppenheimer and CARR
- What is Oppenheimer's price target for CARR?
- Oppenheimer's latest stated price target for Carrier Global Corporation (CARR) is $74, from its action on Aug 16, 2024.
- What is Oppenheimer's rating on CARR?
- Oppenheimer rates CARR Perform, a neutral rating, as of Oct 14, 2025.
- When did Oppenheimer last change its view on CARR?
- On Oct 14, 2025, Oppenheimer downgrades to Perform from Outperform.
- How does Oppenheimer's CARR target compare with other analysts?
- Across 5 firms with a CARR price target in the last 12 months, the median target is $67.
More CARR rating histories
- Wells Fargo3
- Wolfe Research4
- Mizuho5
- Morgan Stanley6
- BofA Securities3
- Robert W. Baird3
- Citigroup3
- Deutsche Bank5
- Credit Suisse3
All Oppenheimer ratingsCARR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.